Gilead Sciences Recent News
Barron's Picks And Pans: Berkshire Hathaway, Carvana, Madison Square Garden And More
Benzinga's Weekly Bulls & Bears: AbbVie, Kinder Morgan, Paypal, Starbucks, Wynn And More
Morgan Stanley Expects Galapagos Shares To Rise 10%
Barron's Picks And Pans: Canadian Stocks, NCR, Gilead And More
Gilead Sciences Price Target Trimmed Following A Sobering Q3
Barron's Picks And Pans: Madison Square Garden, Cigna, Kennedy-Wilson And More
Short Interest Surges In Illumina And Vertex Pharmaceuticals
Short Sellers Dump Amgen And Baxalta
Barron's 500: America's Top Companies
Short Sellers Dump Vertex, Load Up On Baxalta
Big Biotech In The Earnings Spotlight
Barron's: Here Comes $20 Oil
Barron's Picks And Pans: Kinder Morgan, Gilead Sciences And More
Mixed Earnings Expectations For Merck And Pfizer
This Dividend ETF Looks Primed For A Solid 2016
More Wild Short Interest Swings In Biotech Stocks
High Hopes For Apple, Alibaba, Other Earnings This Week
Wild Short Interest Swings For These Three Biotech Stocks
In Volatile Markets, Short Sellers Head For Biotechs
Biogen And Gilead Sciences Catch The Eye Of Short Sellers
What TD Ameritrade Investors Bought And Sold Last Month
Gilead Worth $125 After Earnings: Morgan Stanley
Short Sellers Shy Away From Biotech Stocks